Responses
Poster Presentation
Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy
Compose a Response to This Article
Other responses
No responses have been published for this article.